U.S. Markets close in 30 mins
  • S&P 500

    4,300.14
    +19.99 (+0.47%)
     
  • Dow 30

    33,924.97
    +163.92 (+0.49%)
     
  • Nasdaq

    13,140.44
    +93.25 (+0.71%)
     
  • Russell 2000

    2,020.12
    +3.50 (+0.17%)
     
  • Crude Oil

    89.28
    -2.81 (-3.05%)
     
  • Gold

    1,794.40
    -21.10 (-1.16%)
     
  • Silver

    20.20
    -0.49 (-2.38%)
     
  • EUR/USD

    1.0166
    -0.0092 (-0.8946%)
     
  • 10-Yr Bond

    2.7910
    -0.0580 (-2.04%)
     
  • Vix

    20.02
    +0.49 (+2.51%)
     
  • GBP/USD

    1.2058
    -0.0081 (-0.6656%)
     
  • USD/JPY

    133.3000
    -0.1800 (-0.1348%)
     
  • BTC-USD

    24,116.23
    -177.72 (-0.73%)
     
  • CMC Crypto 200

    573.00
    -17.76 (-3.01%)
     
  • FTSE 100

    7,509.15
    +8.26 (+0.11%)
     
  • Nikkei 225

    28,871.78
    +324.80 (+1.14%)
     

Is LivaNova PLC (NASDAQ:LIVN) Potentially Undervalued?

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

LivaNova PLC (NASDAQ:LIVN), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$86.63 at one point, and dropping to the lows of US$58.96. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether LivaNova's current trading price of US$62.42 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at LivaNova’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for LivaNova

Is LivaNova still cheap?

The stock seems fairly valued at the moment according to my valuation model. It’s trading around 6.8% below my intrinsic value, which means if you buy LivaNova today, you’d be paying a reasonable price for it. And if you believe that the stock is really worth $66.99, then there isn’t much room for the share price grow beyond what it’s currently trading. Furthermore, LivaNova’s low beta implies that the stock is less volatile than the wider market.

What kind of growth will LivaNova generate?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. LivaNova's revenue growth are expected to be in the teens in the upcoming years, indicating a solid future ahead. Unless expenses grow at the same level, or higher, this top-line growth should lead to robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? It seems like the market has already priced in LIVN’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

Are you a potential investor? If you’ve been keeping an eye on LIVN, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. While conducting our analysis, we found that LivaNova has 2 warning signs and it would be unwise to ignore these.

If you are no longer interested in LivaNova, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.